23andMe Investor Presentation Deck

Bill Richards Head of Therapeutics Discovery AMGEN NURA BIO Insights from the 23andMe database Experienced Discovery Leadership Vladimir Vacic Research Fellow, Computational Biology NEW YORK GENOME CENTER Computational Biology Patrick Collins Director, Functional Genomics AMGEN Functional Genomics Antony Symons Senior Director Immunology & Inflammation AMGEN Immunology / Discovery Biology Germaine Fuh Senior Director Antibody & Protein Engineering Copyright © 2024 23andMe, Inc. Genentech Antibody Engineering Experienced team that delivered genetics-based targets from discovery to the clinic 23and Me 35

View entire presentation